|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 51/10 | |
| C07K 16/18 | |||
| C07K 16/28 |
| (11) | Number of the document | 3164159 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15815697.6 |
| Date of filing the European patent application | 2015-06-30 | |
| (97) | Date of publication of the European application | 2017-05-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/038666 |
| Date | 2015-06-30 |
| (87) | Number | WO 2016/004108 |
| Date | 2016-01-07 |
| (30) | Number | Date | Country code |
| 201462019795 P | 2014-07-01 | US | |
| 201562111470 P | 2015-02-03 | US | |
| 201514642497 | 2015-03-09 | US |
| (72) |
ELLWANGER, Kristina, DE
EVNIN, Luke, US
FOX, Judith A., US
FUCEK, Ivica, DE
GUENOT, Jeanmarie, US
KNACKMUSS, Stefan, DE
KUNKEL, Lori, US
LITTLE, Melvyn, DE
MOLKENTHIN, Vera, DE
RAJKOVIC, Erich, DE
REUSCH, Uwe, DE
WALL, Claudia, DE
WEICHEL, Michael, DE
ZHUKOVSKY, Eugene, DE
|
| (73) |
Amphivena Therapeutics, Inc.,
2 Tower Place, Suite 1000, South San Francisco, CA 94080,
US
|
| (54) | BISPECIFIC CD33 AND CD3 BINDING PROTEINS |
| BISPECIFIC CD33 AND CD3 BINDING PROTEINS |